Beovu 6 mg/0.05 mL pre-filled syringe Images
Generic Name: brolucizumab
This medication has been identified as Beovu 6 mg/0.05 mL pre-filled syringe. It is supplied by Novartis Pharmaceuticals Corporation.
Beovu is used in the treatment of Macular Degeneration; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Beovu 6 mg/0.05 mL pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Beovu
- Generic Name
- brolucizumab
- Strength
- 6 mg/0.05 mL pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0827
More about Beovu (brolucizumab)
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
